Nurix Therapeutics, INC. (NRIX) — DEF 14A Filings

All DEF 14A filings from Nurix Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Nurix Therapeutics Files 2025 Proxy Statement — Mar 28, 2025 Risk: low
Nurix Therapeutics, Inc. filed its definitive proxy statement on March 28, 2025, for its annual meeting of stockholders scheduled for May 19, 2025. The filing o
Nurix Therapeutics Announces 2024 Annual Meeting of Stockholders — Mar 27, 2024 Risk: low
Nurix Therapeutics, Inc. (NRIX) filed a Proxy Statement (DEF 14A) with the SEC on March 27, 2024. The 2024 Annual Meeting of Stockholders for Nurix Therapeutics

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX